Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial

E Paci, D Puliti, AL Pegna, L Carrozzi, G Picozzi… - Thorax, 2017 - thorax.bmj.com
Background ITALUNG is contributing to the European evaluation of low-dose CT (LDCT)
screening for lung cancer (LC). Methods Eligible subjects aged 55–69 years, smokers or ex …
被引用次数：310 相关文章

Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial

E Paci, D Puliti, AL Pegna, L Carrozzi, G Picozzi… - Thorax, 2017 - thorax.bmj.com
Background ITALUNG is contributing to the European evaluation of low-dose CT (LDCT)
screening for lung cancer (LC). Methods Eligible subjects aged 55–69 years, smokers or ex …

Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial.

E Paci, D Puliti, AL Pegna, L Carrozzi, G Picozzi… - 2017 - cabidigitallibrary.org
Background ITALUNG is contributing to the European evaluation of low-dose CT (LDCT)
screening for lung cancer (LC). Methods Eligible subjects aged 55-69 years, smokers or ex …

Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial

E Paci, D Puliti, AL Pegna, L Carrozzi, G Picozzi… - 2017 - pubmed.ncbi.nlm.nih.gov
Background ITALUNG is contributing to the European evaluation of low-dose CT (LDCT)
screening for lung cancer (LC). Methods Eligible subjects aged 55-69 years, smokers or ex …

Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial.

E Paci, D Puliti, L Carrozzi, G Picozzi, F Falaschi… - Thorax, 2017 - europepmc.org
Background ITALUNG is contributing to the European evaluation of low-dose CT (LDCT)
screening for lung cancer (LC). Methods Eligible subjects aged 55-69 years, smokers or ex …

Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial

E Paci, D Puliti, AL Pegna, L Carrozzi, G Picozzi… - Thorax, 2017 - search.proquest.com
Background ITALUNG is contributing to the European evaluation of low-dose CT (LDCT)
screening for lung cancer (LC). Methods Eligible subjects aged 55-69 years, smokers or ex …

Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial

E Paci, D Puliti, M Zappa, C Ocello, G Manneschi… - THORAX, 2017 - arpi.unipi.it
Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening
trial IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo Riviste Serie IT Italiano …
[PDF] sirm.org

[PDF][PDF] Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial

E Paci, D Puliti, AL Pegna, L Carrozzi, G Picozzi… - 2017 - areasoci.sirm.org
Background ITALUNG is contributing to the European evaluation of low-dose CT (LDCT)
screening for lung cancer (LC). Methods Eligible subjects aged 55–69 years, smokers or ex …
[PDF] archive.org

[PDF][PDF] Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial

E Paci, D Puliti, AL Pegna, L Carrozzi, G Picozzi… - 2017 - scholar.archive.org
Background ITALUNG is contributing to the European evaluation of low-dose CT (LDCT)
screening for lung cancer (LC). Methods Eligible subjects aged 55–69 years, smokers or ex …
[PDF] academia.edu

[PDF][PDF] Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial

E Paci, D Puliti, AL Pegna, L Carrozzi, G Picozzi… - 2017 - academia.edu
Background ITALUNG is contributing to the European evaluation of low-dose CT (LDCT)
screening for lung cancer (LC). Methods Eligible subjects aged 55–69 years, smokers or ex …